Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 6909

1.

Allogeneic HSCT transfers wild type cystinosin to non-hematological epithelial cells in cystinosis: first human report.

Elmonem MA, Veys K, Arcolino FO, Van Dyck M, Benedetti MC, Diomedi-Camassei F, De Hertogh G, van den Heuvel LP, Renard M, Levtchenko E.

Am J Transplant. 2018 Jul 21. doi: 10.1111/ajt.15029. [Epub ahead of print]

PMID:
30030899
2.

A call to action - The transplant recipient's expectation of precision in transplant medicine.

Wiebe C, Tambur A, Nickerson PW.

Am J Transplant. 2018 Jul 19. doi: 10.1111/ajt.15027. [Epub ahead of print]

PMID:
30022602
3.

Pirfenidone in restrictive allograft syndrome after lung transplantation: A case series.

Vos R, Wuyts WA, Gheysens O, Goffin KE, Schaevers V, Verleden SE, Van Herck A, Sacreas A, Heigl T, McDonough JE, Yserbyt J, Godinas L, Dupont LJ, Neyrinck AP, Van Raemdonck DE, Verbeken EK, Vanaudenaerde BM, Verleden GM.

Am J Transplant. 2018 Jul 18. doi: 10.1111/ajt.15019. [Epub ahead of print]

PMID:
30019840
4.

Hepatic Encephalopathy Impacts the Predictive Value of the Fried Frailty Index.

Tapper EB, Konerman M, Murphy S, Sonnenday CJ.

Am J Transplant. 2018 Jul 18. doi: 10.1111/ajt.15020. [Epub ahead of print]

PMID:
30019835
5.

Long-term outcomes of transmesenteric portal vein recanalization for the treatment of chronic portal vein thrombosis after pediatric liver transplantation.

Cavalcante ACBS, Zurstrassen CE, Carnevale FC, Pugliese RPS, Fonseca EA, Moreira AM, Matushita J Jr, Cândido HLL, Benavides MAR, Miura IK, Danesi VLB, Hirschfeld APM, Borges CBV, Porta G, ChapChap P, Seda-Neto J.

Am J Transplant. 2018 Jul 18. doi: 10.1111/ajt.15022. [Epub ahead of print]

PMID:
30019834
6.

Dramatic Secular Changes in Prognosis for Kidney Transplant Candidates in the United States.

Schold JD, Arrigain S, Flechner SM, Augustine JJ, Sedor JR, Wee A, Goldfarb DA, Poggio ED.

Am J Transplant. 2018 Jul 18. doi: 10.1111/ajt.15021. [Epub ahead of print]

PMID:
30019832
7.

Cardioprotective reperfusion strategies differentially affect mitochondria:studies in an isolated rat heart model of donation after circulatory death (DCD).

Sanz MN, Farine E, Niederberger P, Méndez-Carmona N, Wyss RK, Arnold M, Gulac P, Fiedler GM, Gressette M, Garnier A, Carrel TP, Tevaearai Stahel HT, Longnus SL.

Am J Transplant. 2018 Jul 18. doi: 10.1111/ajt.15024. [Epub ahead of print]

PMID:
30019521
8.

Determinants of Organ Donation Registration.

Shacham E, Loux T, Barnidge EK, Lew D, Pappaterra L.

Am J Transplant. 2018 Jul 18. doi: 10.1111/ajt.15025. [Epub ahead of print]

PMID:
30019496
9.

Glucocorticoids induce corneal allograft tolerance through expansion of monocytic myeloid-derived suppressor cells.

Lee HJ, Park SY, Jeong HJ, Kim HJ, Kim MK, Oh JY.

Am J Transplant. 2018 Jul 18. doi: 10.1111/ajt.15026. [Epub ahead of print]

PMID:
30019411
10.

Extracellular adenosine reversibly inhibits the activation of human regulatory T cells and negatively influences the achievement of the operational tolerance in liver transplantation.

Baroja-Mazo A, Revilla-Nuin B, de Bejar Á, Martínez-Alarcón L, Herrero JI, El-Tayeb A, Müller CE, Aparicio P, Pelegrín P, Pons JA.

Am J Transplant. 2018 Jul 17. doi: 10.1111/ajt.15023. [Epub ahead of print]

PMID:
30019408
11.

A systematic review and meta-analysis of rescue revascularization with arterial conduits in liver transplantation.

Reese T, Raptis DA, Oberkofler CE, de Rougemont O, Györi GP, Gosteli-Peter M, Dutkowski P, Clavien PA, Petrowsky H.

Am J Transplant. 2018 Jul 11. doi: 10.1111/ajt.15018. [Epub ahead of print]

PMID:
29996000
12.

High tacrolimus trough level variability is associated with rejections after heart transplantation.

Gueta I, Markovits N, Yarden-Bilavsky H, Raichlin E, Freimark D, Lavee J, Loebstein R, Peled Y.

Am J Transplant. 2018 Jul 10. doi: 10.1111/ajt.15016. [Epub ahead of print]

PMID:
29989311
13.

Graft dysfunction in simultaneous pancreas kidney transplantation (spk): results of concurrent kidney and pancreas allograft biopsies.

Uva PD, Papadimitriou JC, Drachenberg CB, Toniolo F, Quevedo A, Dotta AC, Chuluyan E, Casadei DH.

Am J Transplant. 2018 Jul 9. doi: 10.1111/ajt.15012. [Epub ahead of print]

PMID:
29985562
14.

Need for a better characterization of HHV-6 infections and associated clinical impacts.

Bonnafous P, Marlet J, Gaudy-Graffin C, Gautheret-Dejean A.

Am J Transplant. 2018 Jul 9. doi: 10.1111/ajt.15013. [Epub ahead of print]

PMID:
29985560
15.

Development and Clinical validity of a novel blood-based molecular biomarker for sub-clinical acute rejection following kidney transplant.

Friedewald JJ, Kurian SM, Heilman RL, Whisenant TC, Poggio ED, Marsh C, Baliga P, Odim J, Brown MM, Ikle DN, Armstrong BD, Charette JI, Brietigam SS, Sustento-Reodica N, Zhao L, Kandpal M, Salomon DR, Abecassis MM.

Am J Transplant. 2018 Jul 9. doi: 10.1111/ajt.15011. [Epub ahead of print]

PMID:
29985559
16.

Effects of everolimus and HLA-G on cellular proliferation and neutrophil adhesion in an in vitro model of cardiac allograft vasculopathy.

Mociornita AG, Adamson MB, Tumiati LC, Ross HJ, Rao V, Delgado DH.

Am J Transplant. 2018 Jul 9. doi: 10.1111/ajt.15015. [Epub ahead of print]

PMID:
29985558
17.

Are We Correctly Assessing Transplant Outcomes by Using Deprivation Indices?

Sharma H, Sharma A, Dhanda R, Mehra S.

Am J Transplant. 2018 Jul 9. doi: 10.1111/ajt.15014. [Epub ahead of print]

PMID:
29985548
18.

No impact of disseminated intravascular coagulation in kidney donors on long-term kidney transplantation outcome: A multicenter propensity-matched study.

Garrouste C, Baudenon J, Gatault P, Pereira B, Etienne I, Thierry A, Szlavik N, Aniort J, Rabant M, Lambert C, Sayegh J, Oniszczuk J, Anglicheau D, Heng AE.

Am J Transplant. 2018 Jul 7. doi: 10.1111/ajt.15008. [Epub ahead of print]

PMID:
29981217
19.

Prognostic tools to assess candidacy for and efficacy of antibody removal therapy.

Pinelli DF, Zachary AA, Friedewald JJ, Gjertson DW, Evans MD, Chatroop EN, Leffell MS, Vo AA, Jordan SC, Montgomery RA, Tambur AR.

Am J Transplant. 2018 Jul 7. doi: 10.1111/ajt.15007. [Epub ahead of print]

PMID:
29981209
20.

Renal transplant from infant and neonatal donors is a feasible option for the treatment of end stage renal disease but is associated with increased early graft loss.

Wijetunga I, Ecuyer C, Martinez-Lopez S, Jameel M, Baker RJ, Wellberry-Smith M, Patel C, Weston M, Ahmad N.

Am J Transplant. 2018 Jul 7. doi: 10.1111/ajt.15006. [Epub ahead of print]

PMID:
29981206

Supplemental Content

Loading ...
Support Center